{"schema_version":"secwatch.filing_event.v1","accession":"0001651308-24-000118","form_type":"8-K","ticker":"ONC","cik":"0001651308","company_name":"BeOne Medicines Ltd.","filed_at":"2024-09-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.966848+00:00","generated_at":"2026-05-31T01:37:05.122657+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BeiGene appoints Shalini Sharp to Board of Directors effective September 27, 2024","bullets":["Shalini Sharp, aged 49, appointed to fill vacancy on board expanded to 12 members.","Former CFO of Ultragenyx Pharmaceuticals (2012-2020) and board member of Neurocrine Biosciences and Organon.","Will receive equity awards valued at $400,000, annual cash compensation of $65,000 plus $17,500 for Audit Committee service.","Appointment effective September 27, 2024; she will serve as Class III director until 2025 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001651308-24-000118","json":"https://secwatch.observer/filing/0001651308-24-000118.json","markdown":"https://secwatch.observer/filing/0001651308-24-000118.md","text":"https://secwatch.observer/filing/0001651308-24-000118.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000118/0001651308-24-000118-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000118/bgne-20240925.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:37:05.122657+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c7534be81a","claim":"Shalini Sharp was appointed as Director at BeOne Medicines Ltd..","evidence_excerpt":"appointed Shalini Sharp to the Board to fill the vacancy, effective September 27, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000118/0001651308-24-000118-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}